87 related articles for article (PubMed ID: 10048946)
21. Hormesis: implications for public policy regarding toxicants.
Lave LB
Annu Rev Public Health; 2001; 22():63-7. PubMed ID: 11274511
[TBL] [Abstract][Full Text] [Related]
22. Organophosphate pesticides and public policy.
Lockwood AH
Curr Opin Neurol; 2002 Dec; 15(6):725-9. PubMed ID: 12447112
[No Abstract] [Full Text] [Related]
23. Comment on "Developing policy in the face of scientific uncertainty: interpreting 0.3 microT or 0.4 microT cutpoints from EMF epidemiologic studies" by Kheifets et al. in Risk Analysis, 25(4), 927-935.
O'Carroll MJ; Henshaw DL
Risk Anal; 2007 Apr; 27(2):285-7; author reply 289-90. PubMed ID: 17511696
[No Abstract] [Full Text] [Related]
24. [A regulatory view on the article: Risk evaluation of carcinogens and their threshold levels, part I-III].
Dieter HH; Konietzka R
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Sep; 49(9):921-5. PubMed ID: 16953360
[No Abstract] [Full Text] [Related]
25. Dioxin and dioxin-like compounds in soil, Part II: technical support document for ATSDR policy guideline.
De Rosa CT; Brown D; Dhara R; Garrett W; Hansen H; Holler J; Jones D; Jordan-Izaguirre D; O'Conner R; Pohl H; Xintaras C
Toxicol Ind Health; 1999 Oct; 15(6):558-76. PubMed ID: 10560134
[No Abstract] [Full Text] [Related]
26. [What is the understanding of the scientific basis and the regulatory toxicology associated with the term "not appreciable " in the risk evaluation of carcinogens].
Dieter HH; Konietzka R; Neumann HG
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Aug; 50(8):1084-5. PubMed ID: 17676413
[No Abstract] [Full Text] [Related]
27. 'Truth in packaging?' The unwrapping of epidemiologic research.
Lanes SF; Poole C
J Occup Med; 1984 Aug; 26(8):571-4. PubMed ID: 6481496
[No Abstract] [Full Text] [Related]
28. FAA turns down the volume.
Greene LA
Environ Health Perspect; 2000 Apr; 108(4):A166. PubMed ID: 10753102
[No Abstract] [Full Text] [Related]
29. Comments on "Children's health, susceptibility, and regulatory approaches to reducing risk from chemical carcinogens".
Landrigan PJ; Mattison DR; Boardman B; Bruckner JV; Jackson RJ; Karol MH; Krewski D; Weil WB
Environ Health Perspect; 2001 Sep; 109(9):A412-3. PubMed ID: 11673132
[No Abstract] [Full Text] [Related]
30. [The risk assessment of cancer morbidity in the joint action of carcinogens].
Shaĭkina OI; Shaĭkin AB; Kon'shina LG
Gig Sanit; 1999; (1):41-3. PubMed ID: 10199078
[No Abstract] [Full Text] [Related]
31. Early indicators of response in biologically based risk assessment for nongenotoxic carcinogens.
Gastel JA
Regul Toxicol Pharmacol; 2001 Jun; 33(3):393-8. PubMed ID: 11407940
[TBL] [Abstract][Full Text] [Related]
32. Minutes of meeting: March 11-12, 1999: Working Group III Report: ethical, legal, and societal issues.
U.S. National Institutes of Health. Recombinant DNA Advisory Committee
Hum Gene Ther; 2000 May; 11(8):1237-42. PubMed ID: 11645217
[No Abstract] [Full Text] [Related]
33. Risk assessment of carcinogens in food.
Barlow S; Schlatter J
Toxicol Appl Pharmacol; 2010 Mar; 243(2):180-90. PubMed ID: 19909764
[TBL] [Abstract][Full Text] [Related]
34. Preimplantation embryos, research ethics, and public policy.
Tauer CA
Bioethics Forum; 1995; 11(3):30-7. PubMed ID: 11653183
[No Abstract] [Full Text] [Related]
35. Risk assessment of carcinogens in food with special consideration of non-genotoxic carcinogens. Scientific arguments for use of risk assessment and for changing the Delaney Clause specifically.
Williams GM; Karbe E; Fenner-Crisp P; Iatropoulos MJ; Weisburger JH
Exp Toxicol Pathol; 1996 Feb; 48(2-3):209-15. PubMed ID: 8672879
[TBL] [Abstract][Full Text] [Related]
36. Vinyl chloride: a case study of data suppression and misrepresentation.
Sass JB; Castleman B; Wallinga D
Environ Health Perspect; 2005 Jul; 113(7):809-12. PubMed ID: 16002366
[TBL] [Abstract][Full Text] [Related]
37. Public health vs. Philip Morris: is it a zero-sum game?
Daynard RA
J Public Health Policy; 2005 Dec; 26(4):469-73. PubMed ID: 16392745
[No Abstract] [Full Text] [Related]
38. RU 486 and the politics of drug regulation in the United States and France.
Kramnick RK
Cornell Int Law J; 1992; 25():667-718. PubMed ID: 11656340
[No Abstract] [Full Text] [Related]
39. Mechanistic and epidemiologic data: when is enough enough?
Roberts R; Ashby J
Environ Health Perspect; 2002 Sep; 110(9):A502-3. PubMed ID: 12269288
[No Abstract] [Full Text] [Related]
40. The logic of vaccination.
Anderson R; May R
New Sci; 1982 Nov; 96(1332):410-5. PubMed ID: 11655494
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
